The use of IL-1 alpha and beta inhibition with ARCALYST has increasingly become the preferred treatment for recurrent ...
Management uses these non-GAAP financial measures when planning, monitoring and evaluating our performance. For more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback